A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma

NCT00059735 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Neoplasms
Carcinoma, Renal Cell
Adenocarcinoma, Renal Cell

Interventions

DRUG: E7070

Sponsor

Eisai Inc.